Analyzing 84263196 COVID-19 Superclasses: 12192 - pneumonia 609748 - emerging infectious disease 3392853 - lung disease 3631290 - lower respiratory tract infection 12136 - disease 18553224 - lower respiratory tract disease 3286546 - respiratory disease 754447 - respiratory tract infection 193181 - observation 19829125 - absence 203066 - relation 2057971 - health problem 567555 - anomaly 621184 - problem 639907 - medical finding 7189713 - physiological condition 813912 - condition 849149 - deviation 18557436 - disease of anatomical entity 18123741 - infectious disease 1150070 - change 1190554 - occurrence 13878858 - natural process 14912053 - nervous system process 160402 - perception 16889133 - class 17008256 - collection 20937557 - series 217594 - class (set theory) 246672 - mathematical object 29182544 - assignment 2996394 - biological process 3249551 - process 3505845 - state 36161 - set 5127848 - class 5469988 - formalization 64732777 - biological phenomenon 7184903 - abstract object 781413 - mental process 855395 - interpretation 864377 - multiset 42417296 - infection associated with diseases 26907166 - temporal entity 16722960 - phenomenon 483247 - phenomenon 35120 - something 58415929 - spatio-temporal entity 1149305 - disposition 16887380 - group 22299483 - system process 4026292 - action 4393498 - representation 488383 - object 494756 - data 25383952 - 1207505 - quality 21170479 - possibility 82785806 - propensity 937228 - property 11028 - information 22299433 - multicellular organismal process 42848 - data 930933 - relation 1475848 - risk factor 156318 - etiology 186290 - correlation 2142347 - environmental factor 2574811 - cause 27166169 - medical study 5850078 - etiology 64705767 - epidemiologic factor 18603648 - contributing factor 21076236 - factor 18603649 - influence Subclasses: Instances: Properties: label Plabel COVID-19 description Pdescription zoonotic respiratory syndrome and infectious disease in humans, caused by SARS coronavirus 2 alias Palias 2019-nCoV acute respiratory disease alias Palias coronavirus disease 2019 alias Palias COVID19 alias Palias COVID 19 alias Palias Covid-19 alias Palias 2019 novel coronavirus pneumonia alias Palias Coronavirus disease 2019 alias Palias nCOVD19 alias Palias nCOVD 19 alias Palias nCOVD-19 alias Palias COVID-2019 alias Palias seafood market pneumonia alias Palias Wuhan pneumonia alias Palias 2019 NCP alias Palias WuRS alias Palias severe acute respiratory syndrome type 2 alias Palias SARS-CoV-2 infection alias Palias 2019 novel coronavirus respiratory syndrome alias Palias Wuhan respiratory syndrome page Ppage Coronavirus_disease_2019 0 0 0 0 0 0 0 828 has cause q 82069695 SARS-CoV-2 1542 has effect q 81068910 COVID-19 pandemic 1542 has effect q 344873 adult respiratory distress syndrome 1542 has effect q 2603200 viral pneumonia 1542 has effect q 261327 Q261327 : 5102 nature of statement q 28962312 often 1542 has effect q 1128440 toxic shock syndrome : 642 of q 7569 child : 5102 nature of statement q 28962310 rarely 1542 has effect q 265936 Kawasaki disease : 518 applies to part q 7569 child : 5102 nature of statement q 28962310 rarely 780 symptoms q 35805 cough 780 symptoms q 114085 rhinitis : 5102 nature of statement q 28962310 rarely 780 symptoms q 38933 fever : 5102 nature of statement q 28962310 rarely 780 symptoms q 767485 respiratory failure : 5102 nature of statement q 28962310 rarely 780 symptoms q 86 headache : 5102 nature of statement q 28962310 rarely 780 symptoms q 474959 myalgia : 5102 nature of statement q 28962310 rarely 780 symptoms q 9690 fatigue : 5102 nature of statement q 28962310 rarely 780 symptoms q 647099 hemoptysis : 5102 nature of statement q 30230067 possibly 780 symptoms q 40878 diarrhea : 5102 nature of statement q 30230067 possibly 780 symptoms q 188008 dyspnea : 5102 nature of statement q 30230067 possibly 780 symptoms q 485831 lymphopenia : 5102 nature of statement q 30230067 possibly 780 symptoms q 344873 adult respiratory distress syndrome : 31 instance of q 1346149 complication : 31 instance of q 177719 medical diagnosis : 1889 different from q 169872 symptom 780 symptoms q 5445 anemia : 5102 nature of statement q 28962310 rarely 780 symptoms q 3961647 cytokine release syndrome : 2868 subject has role q 1931388 cause of death 780 symptoms q 3508755 influenza like illness : 2868 subject has role q 1931388 cause of death 780 symptoms q 468433 anosmia : 2868 subject has role q 1931388 cause of death 780 symptoms q 606216 ageusia : 2868 subject has role q 1931388 cause of death 780 symptoms q 55093125 neurologic manifestation : 642 of q 576349 brain diseases : 5102 nature of statement q 30230067 possibly 780 symptoms q 105688 hypoxia : 642 of q 576349 brain diseases : 5102 nature of statement q 30230067 possibly 780 symptoms q 101991 inflammation : 642 of q 576349 brain diseases : 5102 nature of statement q 30230067 possibly 780 symptoms q 2260058 chills : 642 of q 576349 brain diseases : 5102 nature of statement q 30230067 possibly 780 symptoms q 3245488 nasal congestion : 5102 nature of statement q 28962310 rarely 780 symptoms q 254327 anorexia : 5102 nature of statement q 28962312 often 780 symptoms q 186889 nausea : 5102 nature of statement q 28962312 often 780 symptoms q 167844 conjunctivitis : 5102 nature of statement q 28962312 often 780 symptoms q 183425 abdominal pain : 5102 nature of statement q 28962312 often 1060 pathogen transmission process q 15304519 airborne transmission 1060 pathogen transmission process q 871752 droplet infection 1060 pathogen transmission process q 15304512 contact transmission 1060 pathogen transmission process q 15304504 direct transmission 1060 pathogen transmission process q 88103997 fomite transmission 1060 pathogen transmission process q 971343 poodle : 1480 sourcing circumstances q 18122778 presumably 1060 pathogen transmission process q 21925570 eye infection : 1480 sourcing circumstances q 30230067 possibly 1995 health specialty q 788926 infectious disease 1995 health specialty q 203337 pulmonology 1995 health specialty q 7215 virology 1995 health specialty q 133805 epidemiology 1995 health specialty q 2861470 emergency medicine 3487 maximal incubation period in humans n 14 (573) : 1480 sourcing circumstances q 37113960 estimate 3487 maximal incubation period in humans n 27 (573) : 1480 sourcing circumstances q 37113960 estimate 973 described at URL v https://www.who.int/emergencies/diseases/novel-coronavirus-2019 : 37 official language q 2511187 official languages of the United Nations 973 described at URL v https://emcrit.org/ibcc/covid19/ : 1433 published in q 87646483 Internet Book of Critical Care : 407 language of work or name q 1860 English 973 described at URL v https://www.rtve.es/noticias/20200324/mapa-mundial-del-coronavirus/1998143.shtml : 407 language of work or name q 1321 Spanish 973 described at URL v https://covid19bilgi.saglik.gov.tr/tr/ : 407 language of work or name q 256 Turkish 973 described at URL v https://www.scripps.edu/covid-19/ : 407 language of work or name q 1860 English 973 described at URL v https://covid19.gov.ua/ : 407 language of work or name q 8798 Ukrainian : 407 language of work or name q 1860 English 973 described at URL v https://science.sciencemag.org/content/early/2020/04/02/science.abb7269 : 407 language of work or name q 1860 English 973 described at URL v https://www.cdc.gov.tw/Category/List/AuFztf_j5e4MaYz-sjteNQ : 407 language of work or name q 262828 National language of Republic of China 793 significant event q 81068910 COVID-19 pandemic 3488 minimal incubation period in humans n 2 (573) 575 time of discovery or invention v 1575072000 189 location of discovery q 11746 Wuhan 3984 subreddit e Coronavirus 3984 subreddit e COVID19 1889 different from q 82069695 SARS-CoV-2 1889 different from q 81068910 COVID-19 pandemic 1889 different from q 18975243 coronavirus disease 1889 different from q 16654806 Middle East respiratory syndrome 1889 different from q 278567 severe acute respiratory syndrome-related coronavirus 1889 different from q 103177 severe acute respiratory syndrome 2572 hashtag s COVID19 2572 hashtag s COVIDー19 2572 hashtag s COVID19FOAM : 2441 literal translation v Coronavirus Disease 2019 Free Open Access Medicine 2572 hashtag s CORONAVIRUS : 2441 literal translation v Coronavirus Disease 2019 Free Open Access Medicine 1448 official name v Coronavirus disease 2019 1448 official name v Yeni koronavirüs hastalığı (COVID-19) 1448 official name v 2019冠狀病毒病 1448 official name v 2019冠状病毒病 1448 official name v 코로나바이러스감염증-19 1448 official name v Bệnh virus corona 2019 1448 official name v 嚴重特殊傳染性肺炎 1448 official name v Clefyd coronafirws 2019 1448 official name v করোনাভাইরাস রোগ ২০১৯ 1448 official name v 新型コロナウイルス感染症 1448 official name v โรคติดเชื้อไวรัสโคโรนา 2019 923 medical examinations q 86901049 COVID-19 testing 494 ICD-10 e U07.1 494 ICD-10 e U07.2 7807 ICD-11 (foundation) e 1790791774 699 Disease Ontology ID e DOID:0080600 6680 MeSH term ID e T001007884 486 MeSH descriptor ID e C000657245 : 1810 named as s COVID-19 1813 short name v COVID-19 1813 short name v 코로나19 1813 short name v COVID-19 1813 short name v COVID-19 1813 short name v কোভিড-১৯ 1813 short name v COVID-19 1813 short name v โควิด-19 1813 short name v COVID-19 1813 short name v 武漢肺炎 5551 Courrier international topic ID e covid-19 18 image v COVID-19-Longontsteking.jpg : 2096 media legend v Пневмонія при коронавірусній хворобі 2019, зріз комп'ютерної томограми (показано стрілками затемнення) 924 possible treatment q 3488952 supportive care 924 possible treatment q 846227 antiviral drug 924 possible treatment q 1988216 oxygen therapy 924 possible treatment q 1427096 immunotherapy : 642 of q 422248 monoclonal antibody : 642 of q 87076423 Immunoregulatory Therapy for 2019-nCoV 924 possible treatment q 581996 anti-inflammatory agent : 5004 in opposition to q 1076369 cytokine storm : 5004 in opposition to q 412889 Interleukin 6 : 2176 drug used for treatment q 425154 tocilizumab : 1114 quantity n 400 (3241121) : 636 route of administration q 87757355 intravenous drip 924 possible treatment q 338912 immunoglobulin therapy : 5004 in opposition to q 1076369 cytokine storm : 5004 in opposition to q 412889 Interleukin 6 : 2176 drug used for treatment q 425154 tocilizumab : 1114 quantity n 400 (3241121) : 636 route of administration q 87757355 intravenous drip 924 possible treatment q 249619 immunosuppressive drug : 2176 drug used for treatment q 7424081 Sarilumab 924 possible treatment q 420496 antiserum : 2176 drug used for treatment q 7424081 Sarilumab 3457 case fatality rate n 2.3 (11229) : 17 country q 148 People's Republic of China 3342 significant person q 84497471 Li Wenliang : 2868 subject has role q 26102 whistleblower 3342 significant person q 9096750 Zhong Nanshan : 2868 subject has role q 84862664 risk communication 3342 significant person q 28655382 Chen Shih-chung : 2868 subject has role q 93755388 5806 SNOMED CT identifier e 840539006 557 DiseasesDB e 60833 6694 MeSH concept ID e M000681578 2184 history of topic q 83493517 timeline of the COVID-19 pandemic 2354 has list q 87470473 list of people with coronavirus disease 2019 1120 number of deaths n 7876 (1) : 585 point in time v 1584576000 1120 number of deaths n 9840 (1) : 585 point in time v 1584576000 1120 number of deaths n 4899 (1) : 276 location q 46 Europe : 585 point in time v 1584576000 1120 number of deaths n 18700 (1) : 585 point in time v 1585094400 1120 number of deaths n 47256 (1) : 585 point in time v 1585785600 1120 number of deaths n 58382 (1) : 585 point in time v 1585872000 1120 number of deaths n 69527 (1) : 585 point in time v 1586131200 1120 number of deaths n 82133 (1) : 585 point in time v 1586304000 1120 number of deaths n 102774 (1) : 585 point in time v 1586563200 1120 number of deaths n 116098 (1) : 585 point in time v 1586736000 1120 number of deaths n 126681 (1) : 585 point in time v 1586908800 1120 number of deaths n 145705 (1) : 585 point in time v 1587081600 1120 number of deaths n 160952 (1) : 585 point in time v 1587254400 1120 number of deaths n 185434 (1) : 585 point in time v 1587600000 1120 number of deaths n 202880 (1) : 585 point in time v 1587859200 1120 number of deaths n 217183 (1) : 585 point in time v 1588118400 1120 number of deaths n 238775 (1) : 585 point in time v 1588377600 1120 number of deaths n 257906 (1) : 585 point in time v 1588723200 1120 number of deaths n 282872 (1) : 585 point in time v 1589155200 1120 number of deaths n 302376 (1) : 585 point in time v 1589500800 1603 number of cases n 194909 (1) : 585 point in time v 1584576000 1603 number of cases n 234073 (1) : 585 point in time v 1584576000 1603 number of cases n 374000 (1) : 585 point in time v 1584921600 1603 number of cases n 509164 (1) : 585 point in time v 1585267200 1603 number of cases n 937567 (1) : 585 point in time v 1585785600 1603 number of cases n 1088878 (1) : 585 point in time v 1585872000 1603 number of cases n 1276302 (1) : 585 point in time v 1586131200 1603 number of cases n 1430453 (1) : 585 point in time v 1586304000 1603 number of cases n 1699019 (1) : 585 point in time v 1586563200 1603 number of cases n 1872073 (1) : 585 point in time v 1586736000 1603 number of cases n 1981239 (1) : 585 point in time v 1586908800 1603 number of cases n 2165500 (1) : 585 point in time v 1587081600 1603 number of cases n 2331099 (1) : 585 point in time v 1587254400 1603 number of cases n 2658387 (1) : 585 point in time v 1587600000 1603 number of cases n 2897645 (1) : 585 point in time v 1587859200 1603 number of cases n 3116992 (1) : 585 point in time v 1588118400 1603 number of cases n 3344274 (1) : 585 point in time v 1588377600 1603 number of cases n 3682968 (1) : 585 point in time v 1588723200 1603 number of cases n 4116767 (1) : 585 point in time v 1589155200 1603 number of cases n 4440989 (1) : 585 point in time v 1589500800 2176 drug used for treatment q 425154 tocilizumab : 5102 nature of statement q 30612 clinical trial : 4970 alternate names s Actemra : 176 manufacturer q 212646 Hoffmann-La Roche : 1114 quantity n 400 (3241121) : 636 route of administration q 87757355 intravenous drip 2176 drug used for treatment q 421094 hydroxychloroquine : 1706 together with q 165399 azithromycin : 5102 nature of statement q 41719 hypothesis : 1114 quantity n 600 (3241121) 2176 drug used for treatment q 422438 chloroquine : 5102 nature of statement q 41719 hypothesis 2176 drug used for treatment q 3836750 lopinavir/ritonavir : 5102 nature of statement q 41719 hypothesis 6104 maintained by WikiProject q 87748614 WikiProject COVID-19 5082 Store medisinske leksikon ID e covid-19 : 1810 named as s covid-19 910 topic's main category q 87766827 Category:COVID-19 1151 topic's main Wikimedia portal q 87829288 Portal:COVID-19 7995 NHS Health A to Z ID e coronavirus-covid-19 673 eMedicine ID e 2500114 1583 MalaCards ID e 2019_novel_coronavirus 1296 Gran Enciclopèdia Catalana ID e 23470930 3417 Quora topic ID e COVID 3365 Treccani ID e ricerca/COVID 2347 YSO ID e 38829 5008 on focus list of Wikimedia project q 87748614 WikiProject COVID-19 5642 risk factor q 41861 hypertension 5642 risk factor q 12174 obesity 5642 risk factor q 12206 diabetes mellitus 5642 risk factor q 844935 coronary artery disease 5642 risk factor q 641307 immunodeficiency 5642 risk factor q 762713 hypercholesterolemia 5642 risk factor q 199804 chronic obstructive pulmonary disease 5642 risk factor q 383126 chronic condition 5642 risk factor q 8084905 autoimmune disease 5642 risk factor q 271993 hyperglycemia 5642 risk factor q 826759 status asthmaticus 1245 OmegaWiki Defined Meaning e 1733730 1552 has quality q 87806464 contagiousness 443 pronunciation audio v LL-Q150 (fra)-Fabricio Cardenas (Culex)-Covid-19.wav : 407 language of work or name q 150 French 443 pronunciation audio v LL-Q150 (fra)-Fabricio Cardenas (Culex)-maladie à coronavirus 2019.wav : 407 language of work or name q 150 French 3492 P3492 n 5.7 (1)